+1-888-308-5802     
News Contact Us

Vaccines Market Development History, Current Analysis And Estimated Forecast To 2026

Author : Ronak Bora | Published Date : 2020-11-21 

Global vaccines market share from the adult segment reached USD 17.5 billion in remuneration in 2019 due to the intensifying risk of infections as well as comorbidities in these individuals. The Centers for Disease Control and Prevention estimated that more than 300,000 people are diagnosed with pneumococcal pneumonia annually leading to 150,000 hospitalizations, while the human papillomavirus that affects adults registers 27,000 cancer cases per year. The consistent prevalence of these ailments will bolster the supply and consumption of the vaccines in the coming years.

Demand for hepatitis vaccines will witness significant expansion and the market pegged to register a 12.9% CAGR through 2026, due to the growing episodes of the infection affecting a larger population base as well as the inclining demand and access to the vaccine. As per estimates, over 1.4 million people are infected with hepatitis and other related conditions like liver cancer across the U.S.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/2186

Recombinant vaccines accounted for over 21% of the global revenue in 2019 and the market value is projected to rise over the coming years. A recombinant vaccine solution constitutes of non-replicating plasmids that induce a strong and long-term immune response against pathogens, besides limiting the risk of toxoids reversals and co-purification of undesired contaminants.

Robust technological progressions and consistent prevalence of viral infections like COVID-19 that need extensive R&D will stimulate the demand for vaccines in the coming years. Vaccines can be accounted as an effective and clinically proven preventive treatment approach for diseases.

Europe vaccines market held 28% of the total global revenue in 2019 and is likely to gain momentum through the coming years owing to a spike in R&D activities and healthcare spending across the region. The ongoing COVID-19 outbreak has urged the implementation of various developmental activities by multiple firms to offer effective vaccines. The region is also witnessing a surge in government efforts to manage the production and distribution of various types of vaccines.

Solution providers are working on various strategies and partnerships to expand their business profile and customer base along with the commercialization of newer vaccinations to gain a competitive edge. The companies are exclusively focused on trials for novel coronavirus treatment. In April 2020, Sanofi collaborated with GlaxoSmithKline (GSK) for the development of the COVID-19 vaccine. Abbott Laboratories, Merck, AstraZeneca, and Pfizer are few other vaccines suppliers globally.

Request for customization @ https://www.decresearch.com/roc/2186

Partial Chapter of the Table of Content

Chapter 4. Vaccines Market, By Age Group

4.1. Key segment trends

4.2. Pediatric

4.2.1.  Market size, by region, 2015 - 2026 (USD Million)

4.3. Adult

4.3.1.  Market size, by region, 2015 - 2026 (USD Million)

Chapter 5. Vaccines Market, By Disease

5.1. Key segment trends

5.2. Cancer

5.2.1.  vaccines market size, by region, 2015 - 2026 (USD Million)

5.3. Hepatitis

5.3.1.  Market size, by region, 2015 - 2026 (USD Million)

5.4. Pneumococcal disease

5.4.1.  Market size, by region, 2015 - 2026 (USD Million)

5.5. DTP

5.5.1.  vaccines market size, by region, 2015 - 2026 (USD Million)

5.6. Dengue

5.6.1.  Market size, by region, 2015 - 2026 (USD Million)

5.7. Influenza

5.7.1.  Market size, by region, 2015 - 2026 (USD Million)

5.8. Human papilloma virus

5.8.1.  vaccines market size, by region, 2015 - 2026 (USD Million)

5.9. Meningococcal disease

5.9.1.  Market size, by region, 2015 - 2026 (USD Million)

5.10.  Polio

5.10.1. Market size, by region, 2015 - 2026 (USD Million)

5.11.  Rotavirus

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/vaccines-market

 

About Author

Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for fractovia and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport. [email protected] | https://twitter.com/RonakBora26

Related News

North America Aerospace Avionics Market to gain traction by 2025

Published Date: 2020-11-27         Author: Ronak Bora

The study on North America Aerospace Avionics Market provides a complete view on the industry with intricate details subject to its overall stance in the global landscape along with specifying various applications across major end-user sectors. North America aerospace avionics industry, as per the g... Read More

North America Aerospace Avionics Market to gain traction by 2025

Published Date: 2020-11-27         Author: Ronak Bora

... Read More

North America Biogas Market to amass significant gains by 2025

Published Date: 2020-11-27         Author: Ronak Bora

The market analysis on North America Biogas Market provides a holistic view on the overall industry along with laying significant focus on crucial details pertaining to its foothold in the global economy and its applications across multiple end-user industries and sectors. According to the given rep... Read More

© 2020 Fractovia. All Rights Reserved